Rare Cancers – more common than you think
ESMO Video Commentary:
Novelties in head and neck cancer
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers 2016
Milan, Italy - 25 Nov - 27 Nov 2016 - Find out more here
18 Aug 2016
CAR T-cells Targeting the CD4 Protein Granted FDA Orphan Drug Designation
The indication concerns the treatment of peripheral T-cell lymphoma
25 Jul 2016
Improving care for patients with rarecancers. Are European reference networks the answer?
How can these cross-border healthcare structures improve the quality of care received by the almost half a million Europeans who are diagnosed with a rare cancer each year?
08 Jul 2016
Protein flags the worst glioblastomas
Glioblastoma patients with a protein called oncostatin M receptor on their tumours face a particularly poor prognosis